# Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026
Canonical URL: https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-second-quarter-2026-financial-results-on-july-22-2026
Ticker: MEDP
Company: Medpace
Source: Medpace
Published: 2026-06-25 13:46 EST
Original Source URL: https://investor.medpace.com
## Summary

CINCINNATI --(BUSINESS WIRE)--Jun. 16, 2026-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday,

## Article Body
CINCINNATI --(BUSINESS WIRE)--Jun. 16, 2026-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced that it will report its second quarter 2026 financial results after the market close on Wednesday, July 22, 2026. The Company will host a conference call the following morning, Thursday,
## Recent Company News
- 2026-06-25 13:46 EST — [Medpace Holdings, Inc. to Report Second Quarter 2026 Financial Results on July 22, 2026](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-second-quarter-2026-financial-results-on-july-22-2026) — Source: Medpace
- 2026-06-25 13:46 EST — [Medpace Holdings, Inc. to Report First Quarter 2025 Financial Results on April 21, 2025](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-first-quarter-2025-financial-results-on-april-21-2025) — Source: Medpace
- 2026-06-25 13:46 EST — [Medpace Holdings, Inc. Reports First Quarter 2025 Results](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-reports-first-quarter-2025-results) — Source: Medpace
- 2026-06-25 13:46 EST — [Medpace Holdings, Inc. to Report Second Quarter 2025 Financial Results on July 21, 2025](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-to-report-second-quarter-2025-financial-results-on-july-21-2025) — Source: Medpace
- 2026-06-25 13:46 EST — [Medpace Holdings, Inc. Reports Second Quarter 2025 Results](https://biopharmsignal.com/news/MEDP/medpace-holdings-inc-reports-second-quarter-2025-results) — Source: Medpace
## Related News
- 2026-07-21 12:00 EST — MOR — [Novartis delivered sales growth in Q2 and further advanced the pipeline; Full-year guidance reaffirmed](https://biopharmsignal.com/news/MOR/novartis-delivered-sales-growth-in-q2-and-further-advanced-the-pipeline-full-yea-63a32b47)
- 2026-07-21 10:28 EST — GSK — [ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults alongside INSTI-powered long-acting injectable innovation at AIDS 2026](https://biopharmsignal.com/news/GSK/viiv-healthcare-to-present-phase-iiib-data-comparing-dovato-with-biktarvy-in-tre-1ff3f640)
- 2026-07-20 20:05 EST — RANI — [Rani Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/RANI/rani-therapeutics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-ec56b3b0)
- 2026-07-20 14:53 EST — IPHA — [Innate Pharma announces Completion of Enrollment in Phase 1 Dose Escalation Study of IPH4502, a Novel Nectin-4 Exatecan Antibody-Drug Conjugate (ADC)](https://biopharmsignal.com/news/IPHA/innate-pharma-announces-completion-of-enrollment-in-phase-1-dose-escalation-stud-0778493f)
- 2026-07-20 13:05 EST — ACAD — [Acadia Pharmaceuticals Receives FDA Fast Track Designation for Remlifanserin in Alzheimer's Disease Psychosis](https://biopharmsignal.com/news/ACAD/acadia-pharmaceuticals-receives-fda-fast-track-designation-for-remlifanserin-in--f36b622c)